Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Palm Beach, FL – March 10, 2025 – A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...

Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

Aclarion, Inc. (NASDAQ:ACON) experienced a dramatic decrease of 74.13% in its stock price. Elevai Labs, Inc. (ELAB) saw a substantial price drop of 42.63%. Sleep Number Corporation (SNBR) reported a ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

The additional sites RadNet is onboarding will help us enable more convenient access to grow scan volume in response to physician demand. It also underscores our strong relationship with this ...

Healthcare technology firm Aclarion Inc.'s (ACON) stock surged nearly 127% on Monday, marking its best single-day gain since ...

Aclarion shares are trading higher by 124% during Monday's session. The company announced it signed a commercial deal with ...

March 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro ...

Aclarion shares rise on partnership with Scripps Health in San Diego, CA. The agreement brings Nociscan to Southern ...

Aclarion, Inc. (NASDAQ:ACON – Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 247,100 shares, an ...